| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.22▲ | 1.22▲ | 1.22▲ | 1.22▲ | 1.29▼ |
| MA10 | 1.22▲ | 1.21▲ | 1.22▲ | 1.23▲ | 1.81▼ |
| MA20 | 1.22▲ | 1.23▲ | 1.23▲ | 1.23▼ | 2.25▼ |
| MA50 | 1.22▲ | 1.23▲ | 1.24▼ | 1.86▼ | 2.27▼ |
| MA100 | 1.23▲ | 1.24▼ | 1.22▲ | 2.25▼ | 1.83▼ |
| MA200 | 1.23▲ | 1.21▲ | 1.44▼ | 2.31▼ | 1.67▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.001▲ | -0.001▼ | 0.044▲ | -0.169▼ |
| RSI | 63.727▲ | 54.724▲ | 52.279▲ | 32.788▼ | 27.562▼ |
| STOCH | 88.889▲ | 60.000 | 30.875 | 63.927 | 7.534▼ |
| WILL %R | 0.000▲ | -33.333 | -57.895 | -40.000 | -92.500▼ |
| CCI | 147.287▲ | 82.260 | -12.491 | 19.617 | -106.849▼ |
|
Wednesday, August 12, 2026 05:00 PM
Key Points Interested in Spero Therapeutics, Inc.? Here are five stocks we like better. Utebzi was approved by the FDA for certain complicated urinary tract infections, with GSK expected to ...
|
|
Wednesday, August 05, 2026 09:05 AM
Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that on July 22, 2026 ...
|
|
Friday, July 24, 2026 02:59 PM
Short interest in Spero Therapeutics Inc (NASDAQ:SPRO) increased during the last reporting period, rising from 1.83M to 2.86M. This put 5.97% of the company's publicly available shares short. Based on ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/08/26 | 1.26 | 1.26 | 1.1937 | 1.23 | 744,533 |
| 13/08/26 | 1.26 | 1.30 | 1.21 | 1.24 | 1,283,701 |
| 12/08/26 | 1.24 | 1.245 | 1.185 | 1.19 | 754,794 |
| 11/08/26 | 1.24 | 1.25 | 1.21 | 1.23 | 362,559 |
| 10/08/26 | 1.25 | 1.276 | 1.225 | 1.23 | 348,491 |
| 07/08/26 | 1.27 | 1.2795 | 1.24 | 1.26 | 457,178 |
| 06/08/26 | 1.26 | 1.275 | 1.235 | 1.27 | 777,297 |
| 05/08/26 | 1.25 | 1.28 | 1.22 | 1.26 | 574,325 |
| 04/08/26 | 1.15 | 1.245 | 1.15 | 1.23 | 751,946 |
| 03/08/26 | 1.18 | 1.22 | 1.125 | 1.15 | 1,372,578 |
|
|
||||
|
|
||||
|
|